-$0.24 EPS Expected for PDS Biotechnology Co. (NASDAQ:PDSB) This Quarter

Wall Street analysts expect that PDS Biotechnology Co. (NASDAQ:PDSB – Get Rating) will post ($0.24) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for PDS Biotechnology’s earnings. The lowest EPS estimate is ($0.25) and the highest is ($0.22). PDS Biotechnology posted earnings per share of ($0.14) in […]

Related Keywords

,Morgan Stanley ,Biotechnology Corp ,Zacks Investment Research ,Blackrock Inc ,Commonwealth Equity Services ,Nasdaq ,Biotechnology Company Profile Get Rating ,Biotechnology Co ,Clarity Wealth Management Inc ,Valeo Financial Advisors ,Wall Street ,Get Rating ,Investment Research ,Clarity Wealth Management ,Equity Services ,Financial Advisors ,Company Profile ,Pds Biotechnology ,Nasdaq Pdsb ,Pdsb ,Medical ,Ratings ,Consensus ,